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Abstract
Background: Opioid addiction causes many preventable deaths across the United States. Many
recommendations to prevent opioid addiction have been made, however, many recommendations
have not been fully evaluated for efficacy. This has led to a gap in knowledge for providers and
healthcare systems to make informed decisions on how to reduce opioid addiction.
Objectives: This study explores different prescriber-based opioid prevention strategies,
providing an analysis and ranking for the strategies that most effectively reduce opioid abuse and
exposure. Additionally, the analysis provides recommendations for future research.
Methods: An integrative literature review was conducted to investigate three opioid abuse
prevention strategies: prescription drug monitoring programs, physician continuing education,
and risk assessment screening tools. Information has been organized according to prevention
strategy type and presented in a data matrix table.
Results: Most studies (4 out of 5) that examined risk assessment screening tool concluded that
their use resulted in statistically significant reductions in opioid abuse. Prescription drug
monitoring programs had more mixed results but overall resulted in modest reductions.
Physician continuing education resulted in very few statistically significant outcomes.
Discussion: The opioid abuse prevention strategies have the greatest to the least impact in the
following order 1) risk assessment screening tools 2) prescription drug monitoring programs, and
3) prescriber continuing education.
Keywords: Opioids, opioid abuse prevention, opioid addiction prevention, prescription drug
monitoring programs, physician continuing education, risk assessment screening tool, risk
assessment questionnaire, opioid abuse prevention strategies
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A Comparison of Prescriber-Based Opioid Addiction Prevention Strategies:
An Integrative Literature Review
Introduction
Opioid addiction can be seen on the streets, in the emergency room and even in pictures
posted on social media. In 2017, police officers of East Liverpool, Ohio posted a very graphic
and controversial picture on social media as a cry for help (Park, 2017). In the picture, a young
boy stares blankly at the camera while his two caregivers are unconscious from a heroin
overdose in the front seat of their car. The picture is a haunting representation of the current
United States opioid addiction epidemic. According to the Center for Disease Control and
Prevention (2016), “deaths from prescription opioids—drugs like oxycodone, hydrocodone, and
methadone—have more than quadrupled since 1999” (Understanding the Epidemic section, para.
1). Additionally, the CDC reports that 91 Americans die from opioids every day. The epidemic
affects so many people that the use of NARCAN (an opioid antagonist) is now taught at basic
provider level CPR classes.
This is an epidemic that affects people throughout the lifespan and across all
demographic variables. According to Richter, Kunz, & Foster (2015), since 2010, opioids are the
leading cause of death in people between the ages of 12 years old and 50 years old, affecting
older adults and adolescents as well. Additionally, the National Center on Addiction and
Substance Abuse (NCASA, 2017) reports that “opioid related deaths have risen across virtually
all demographic groups and in almost every state in the nation” (pg. 4). Illinois alone has lost
over 11,000 people to the opioid epidemic since 2008 with projections of the loss of nearly 3,000
more lives by the year 2020 (State of Illinois, 2017).
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In addition to the fact that the opioid epidemic has a profound impact on different
demographics and causes many preventable deaths, it also represents a huge cost. The NCASA
(2017) estimates that states spend an average of nearly sixteen percent of their budget combating
substance abuse and addiction, with that spending being primarily on consequences rather than
prevention. Other economists have estimated that paying for one year of costs related to the
opioid epidemic exceeds 78.5 billion dollars (Florence, Xu, & Zhou, 2016).
This epidemic carries very meaningful implications for healthcare industry professionals.
Healthcare providers have worsened the situation according to many studies. “Opioid addiction
can actually begin with a trip to the emergency room. A wide variation in rates of opioid
prescribing existed among physicians practicing within the same emergency department, and
rates of long-term opioid use were increased among patients who had not previously received
opioids and received treatment from high-intensity opioid prescribers” (Barnet, Olenski, &
Anupman, 2017, p. 663). In fact, some studies estimate that almost sixty percent of opioids being
abused come from a physician prescription, either directly or indirectly (Lembke, 2016).
Furthermore, it is important to note that increasing addiction rates correspond to an increase in
pharmaceutical opioid sales (Hahn, 2011). This information demonstrates that as providers write
more opioid prescriptions, rates of opioid abuse increase. Finally, we must note that, the majority
of heroin users today began by misusing prescription opioids (NCASA, 2017).
This problem is exacerbated by a few factors. First, many providers recognize addiction
but do not know how to treat it (Lembke, 2016). Second, many providers underutilize current
prevention strategies. For example, while nurse practitioners wrote over 4,000,000 prescriptions
for opioids in 2013 (Chen, Humphrey, Shah, & Lembke, 2015), only about 20.9% of family
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nurse practitioners utilized formal screening devices for opioid abuse in their patients
(Chaudhary, & Compton, 2017).
Many recommendations for dealing with the opioid epidemic have been proposed. While
numerous patient/user based initiatives exist, this paper will focus on behavioral changes on the
part of prescribers of opioids due to the fact that “the misuse of prescription opioids precedes the
use of heroin and other illicit opioids in the majority of cases” (NCASA, 2017, p.17). Some of
the most widely recommended prescriber-centered strategies include: the use of prescription
drug monitoring programs, changes in prescribing guidelines, prescriber continuing education,
and substance abuse screening tools.
With so many recommendations for combating the opioid crisis, providers and healthcare
systems might not know where to start. According to Hahn (2011), many of the recommended
strategies have not been fully evaluated for efficacy nor broadly implemented. This has caused a
knowledge gap regarding best practice. An integrative literature review could gather and analyze
data with the intention of recommending one or two strategies that have higher efficacy rates.
This data could then be used to help providers and healthcare systems invest resources in
evidence-based strategies to reduce opioid addiction.
This integrative literature review aims to better understand different prescriber-based
opioid prevention strategies, providing an analysis and ranking for the strategies that most
effectively reduce opioid abuse and exposure. Additionally, the analysis will provide
recommendations for future research.
To better understand which opioid prevention strategy has the most efficacy, the
following research question will guide this integrative literature review: Which prescriber-based
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opioid prevention strategy most effectively reduces opioid abuse? For the purposes of this study,
effective reduction in opioid abuse is defined as a decrease in: “significant negative
consequences of using opioids recurrently” (Hahn & Cataldo, 2012, p.1).
Conceptual Framework
This study draws on Nola Pender’s health promotion conceptual framework for guidance.
Nola Pender’s health promotion model explores “the complex biopsychosocial processes that
motivate individuals to engage in behaviors directed toward the enhancement of health”
(Murdaugh, Parsons, & Pender, 2002, p. 60). Pender’s framework maintains two theoretical
foundations: 1.) behavior is rational and economical, and 2.) the environment, personal factors
and behavior all shape one another (Murdaugh, Parsons, & Pender, 2002, p. 62). There are
various assumptions that Pender states in her conceptual framework, but there are three
assumptions particularly relevant to this integrative literature review. First, people want to
express their full health potential. Second, people are highly affected by healthcare professionals.
Finally, people change their environment and their environment changes them.
Pender’s assumption that patients want to express their full health potential gives
researchers a starting point. If we assume that patients want to express their full health potential,
we can assume they want to prevent opioid addiction, as this would diminish health potential.
Then the question “how?” may be asked. Drawing from the model for further guidance, we know
that people are both affected by their environment and by healthcare professionals. This moves
us to study prescriber-based prevention strategies because we know that providers not only form
part of the patient’s environment, but affect the patients directly. Thus, prescriber-based
prevention strategies and health promotion have the potential to reduce opioid addiction.
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Finally, researchers can use Nola Pender’s Health Promotion model “to provide a coherent and
organized framework for intervening with clients to increase health promoting behaviors”
(Murdaugh, Parsons, & Pender, 2002, p.75).
Figure 1 Visual Depiction of Nola Pender’s Health Promotion model

Methods
Design
This research utilized an integrative literature review design for various reasons. First,
integrative literature reviews, among many things, help identify gaps in knowledge, bridge
related areas of work and help determine relevant areas for future research (Russell, 2016). This
particularly relates to prescriber-based opioid prevention strategies because information about
each individual prevention strategy is available, but current research lacks a comparison to
determine best practice. This integrative literature review synthesized information about three
prescriber-based opioid addiction prevention strategies: prescription drug monitoring programs,
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risk assessment screening tools, and prescriber continuing education. Prescription drug
monitoring programs store information about patients, providers, prescriptions, pharmacies and
other information such as medication date dispensed, type and strength (Ringwalt et al., 2015).
Risk assessment screening tools vary depending on the type. Generally, patients provide
information that will in turn indicate how many risk factors they have that predispose them to
opioid addiction. Providers then use this information to guide their prescribing practices.
Prescriber continuing education includes any workshops or training aimed to educate providers
on opioids and risks associated with opioid prescriptions. Using a side-by-side comparison of
each strategy enabled interested parties to determine the best strategy and identify areas that
require further research.
Literature Search Strategies
Multiple databases contributed information to this integrative literature review. A
separate search was conducted for each prevention strategy, utilizing two databases to gather
results for each strategy. For prescriber continuing education, queries were completed in PubMed
and Cumulative Index to Nursing and Allied Health Literature (CINAHL) complete. PubMed
and CINAHL were used to obtain information on prescription drug monitoring programs.
Finally, PubMed, and ProQuest Nursing, and Allied Health Database were searched to find
information about risk assessment screening tools.
Search terms varied for each separate prevention strategy. Search terms for prescriber
continuing education included: opioid abuse prevention OR opioid addiction prevention AND
prescriber education OR continuing education OR physician training OR physician education.
For the risk assessment screening tool search, terms included: opioid addiction prevention OR
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opioid abuse prevention AND risk assessment screening tool OR risk assessment questionnaire.
For the inquiry on prescription drug monitoring programs, the following were terms included in
the search: opioid abuse prevention OR opioid addiction prevention, AND prescription drug
monitoring program OR prescription drug program OR pdmp AND effectiveness OR efficacy
OR result.
Literature Inclusion/Exclusion Criteria and Data Screening
For this integrative literature review, the main inclusion criteria were: 1) the primary
focus of the abstract related to opioid addiction prevention, 2) the article focused on one of the
three aforementioned prevention strategies, and 3) the article was a primary source. Additionally,
articles must have been published in the last five years, be peer reviewed, be published in
English, and have human subjects. Research was excluded based on information in the abstract
or title if it: 1) did not conduct an intervention with measurable results, and 2) presented an
intervention for addiction to substances other than opioids (see figure 1, figure 2, & figure 3).
Data Analysis
Information extracted from the selected studies in this integrative literature review
included: author information, purpose statement, research question, information about the sample
(including demographics and sample size), method, prevention strategy and results of the study.
The selected studies were organized into separate tables according to the specific prescriberbased prevention strategy. Table 1 summarizes information about the studies involving
prescription drug monitoring programs. Table 2 summarizes information about the studies
involving risk assessment screening tools and table 3 summarizes information from the studies
involving prescriber continuing education.
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The data summarized in the tables provides information about each individual strategy,
allowing for a side by side comparison. As such, strategies were assessed for efficacy and
ultimately, ranked, providing information about which method is most effective in preventing
opioid addiction.
Results
This integrative literature review includes thirteen articles, each selected to help determine
which prescriber-based opioid prevention strategy most effectively reduces opioid abuse. Of the
thirteen articles included in this review, five articles assessed the efficacy of prescription drug
monitoring programs, four articles measured the results of risk assessment screening tools and
four articles evaluated the efficacy of prescriber continuing education.
Prescription Drug Monitoring Programs
Prescription drug monitoring programs (PDMPs) have four effects on the opioid
epidemic. First and foremost, prescription drug monitoring programs result in a statistically
significant reduction in prescribing and overall use of opioids. Alexander et al. (2016) showed
that the implementation of a PDMP in the state of Florida (as compared to the control state of
Georgia) decreased opioid prescriptions by 1.4%, decreased opioid volume by 2.5% and
decreased the morphine milligram equivalent by 5.6%. The Reisman, Shenoy, Atherly, &
Flowers (2009) research yielded similar results. They looked at states with active and stable
PDMPs between the years 1997-2003. Because oxycodone use correlates highly with opioid
abuse (compared to morphine or hydrocodone) they focused on rates of oxycodone prescription.
Their research showed that states with PDMPs saw lower rates of oxycodone prescription and
lower correlating rates of prescription opioid abuse admissions to hospitals.
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Second, PDMPs impact prescribing/dispensing behaviors. Norwood & Wright (2016)
used a cross sectional study to analyze whether the use of a PDMP would impact pharmacist
dispensing patterns. Their paper demonstrated that consistent use of PDMPs made a change in
dispensation practice 6.4 times more likely and refusal of dispensation 3.3 times more likely.
Additionally, the Indiana state annual rate of refused dispensation increased from 7 to 25.
Furthermore, Alexander et al. (2016) showed that the providers most impacted by using PDMPs
were those with the highest baseline prescribing patterns.
Third, PDMPs can be used to assess addiction in patients and better understand which
patients run the risk of high exposure to prescription opioids. Individuals with mental health
issues often have a dual diagnosis (of substance abuse and a mental health disorder), thus, the
opioid epidemic affects these individuals disproportionately. Using a PDMP, Hackman et al.
(2015) found that 57% of patients receiving care at a mental health clinic in Indiana received a
prescription for opioids. This number far exceeds the average number of individuals receiving
opioid prescriptions nationwide. Additionally, they found that a higher number of prescriptions
per patient significantly increased the odds of an opioid dependence diagnosis.
Finally, PDMPs have successfully demonstrated a correlation between high risk
prescribers and patient overdoses. Ringwalt et. al (2015) utilized death records in conjunction
with a PDMP to establish a connection between aberrant prescribing practices and opioid
overdoses. Their research showed that overdoses often resulted from providers who prescribed:
“(1)benzodiazepines in conjunction with high levels (100 MMEs) of opioids, (2) opioids
regardless of dose, (3) high level opioids, and (4) benzodiazepines” (Ringwalt et. al, 2015,
pg.293).
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Risk Assessment Screening Tools
All four articles that evaluated risk assessment screening tools concluded that they
demonstrate a strong ability to predict, identify and potentially mitigate the risk of opioid abuse.
Aldridge, Linford, & Bray (2017) showed that using the Screening, Brief Intervention Referral to
Treatment (SBIRT) tool reduced illicit drug use by 78.5%. While the tool used in the article by
Barclay, Owens, & Blackhall (2014) differed from the SBIRT, it demonstrated similarly striking
results. Barclay, Owens, & Blackhall (2014) analyzed the Opioid Risk Tool (ORT). The ORT
showed that high risk scores from the screening tool strongly predicted abnormal urine drug
screens. For example, only 7% of people who scored low on the ORT had abnormal drug tests
as compared to the 62.5% of people who scored high on the ORT with abnormal drug test. Olivia
et al. (2017) found that using applied informatics, STORM (a screening tool) could predict 50%
of the patients that could potentially have an overdose or drug related suicide event in a given
year.
Prescriber Continuing Education
Three of the four articles that evaluated prescriber continuing education concluded that it
yielded little to no statistically significant effect on opioid prescribing rates. Holliday et al.
(2017) showed that some providers demonstrated an initial decrease in opioid prescribing but
that those decreases were not sustained. Kahan et al. (2013) determined that continuing
education had no effect on initial nor long term prescribing rates. The research published by
Osborn, Yu, Vasilyadis, Craig, & Blackmore (2017) was an exception, showing a significant
reduction in prescribing rates. This study combined a mandated department wide policy change
in opioid prescribing (based on the Washington E.D. Opioid Abuse Work Group guidelines) with
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a continuing education. Prescribers were taught the new guidelines and researchers then looked
at prescribing rates pre-and post-intervention. Not only did the intervention reduce opioid
prescriptions by 39% but the reductions were sustained long term.
Discussion
Findings
This paper aimed to understand which strategy to decrease opioid addiction would
produce the greatest reduction in opioid prescribing and/or abuse rates. Based on interpretation
of the results, the strategies have the greatest to the least impact in the following order: 1) risk
assessment screening tools 2) prescription drug monitoring programs, and 3) prescriber
continuing education.
Risk assessment screening tools showed the most promise in combating the opioid
epidemic as all four articles that looked at this intervention strategy reported statistically
significant outcomes. One study showed reductions as high as 78.5% in substance abuse.
Another study showed a significant correlation between high risk scores on an opioid risk
screening tool and subsequent abnormal drug screens. Two studies didn’t report a direct
reduction in opioid abuse, however, they demonstrated a strong ability to predict which patients
were susceptible to opioid abuse. With this knowledge, providers could alter prescribing
practices and make treatment referrals accordingly, ultimately reducing opioid abuse.
One limitation to drawing definitive conclusions regarding the efficacy of risk assessment
screening tools is that each study used different screening tools. At least three different risk
assessment screening tools (STORM, ORT, and SBIRT) were used by the researchers. Each of
these screening tools produced different results, so while overall, we know that screening tools
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have produced successful outcomes, we do not know what accounts for the differences between
the outcomes. Did STORM as a screening tool outperform the ORT or was the study that utilized
STORM designed better? Using a standardized screening tool could strengthen this research and
allow for easy replication.
Prescription drug monitoring programs showed a smaller direct impact on opioid abuse
than risk assessment screening tools. Decreases in opioid use were more modest using PDMPs,
with some figures only as high as about 5%. However, PDMPs can help indicate which providers
have risky prescribing practices. Providers with risky prescribing practices can greatly increase
the risk of opioid dependence and overdose. Ringwalt et. al (2015) demonstrated that between
30-45% of providers with the riskiest prescribing patterns had prescribed an opioid analgesic to a
patient within 30 days of his or her death. Additionally, PDMPs can be used to flag patient at risk
for multiple opioid prescriptions. While PDMPs suggest more modest outcomes in relation to
direct opioid abuse reduction, their other benefits probably indirectly reduce opioid abuse
substantially.
PDMP results had limitations as well. Studies did not use consistent subjects in their
interventions. Looking at the five articles examining PDMPs, two articles used states as their
subjects. One article examined multiple states pre-and post-implementation of a PDMP, and the
other examined one state using a PDMP (Florida) against a control state (Georgia). The other
articles evaluated the efficacy of using a PDMP but varied their subjects (pharmacists, patients
with dual diagnoses, etc).
Prescriber education, although seeming to have little impact on opioid addiction, can be
effective when combined with a mandated policy change. Osborn, Yu, Vasilyadis, Craig, &
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Blackmore (2017) showed that by using recommended guidelines to mandate a policy change
department wide in an E.D., they reduced opioid prescriptions by 39% in that E.D. The state of
Ohio saw similar results after creating policy changes surrounding opioid prescribing. According
to Penm et al. (2017), the governor of Ohio created the Governor’s Cabinet Opiate Action Team
(GCOAT) in 2011, which had three goals: 1) to promote the responsible use of opioids, 2) to
reduce the supply of opioids, and 3) to support overdose prevention and expand access to
naloxone. In order to achieve this goal, they released prescribing guidelines encouraging
practitioners to consider non-opioid therapies first. In 2015, four years after implementing these
guidelines, the state of Ohio saw 81 million fewer doses of opioids dispensed than in 2011
(Penm et al., 2017).
Limitations
The lack of evidence based research on opioid prevention strategies limited the scope of
this paper substantially and represents the largest barrier to formulating concrete solutions to the
opioid epidemic. Even finding thirteen articles that fit within the search criteria proved to be
difficult. A larger pool of relevant literature would strengthen this integrative literature review.
As discussed in the findings section, another barrier of this integrative literature review
was the lack of consistency in subjects and study design. This was further complicated by the
fact that within each category of prevention strategy, interventions varied significantly. This
made standardizing the results into an average percentage for each overall strategy impossible.
Nursing Implications
This integrative literature review identifies a critical knowledge gap that needs to be
researched in order to effectively combat the opioid crisis. Emergency department nurses and
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psychiatric nurses occupy a particularly relevant position in that they have the most contact with
patients who abuse opioids. This gives these nurses specialized knowledge and the ability to
conduct research on the topic given the frequency of their contact with this population. As nurses
strive to increase their participation in research, this presents an opportunity for nurses to
conduct research in an urgently needed area.
This research also carries the implication of advocacy. Based on the finding of this
integrative literature review, utilizing PDMPs, screening tools, and mandated policy changes
surrounding the prescribing of opioids all suggest the ability to decrease opioid abuse. To best
support patients, nurses must advocate for policies that will decrease negative outcomes, such as
those listed above.
Recommendations for Future Research
At this point, people understand the gravity of the opioid epidemic but don’t seem to have
concrete solutions to combat it. In conducting research for this paper, it became clear that
evidence based research to support the use of a specific strategy to combat the opioid epidemic is
lacking. Considering that risk assessment screening tools and using mandated prescribing policy
changes showed promising results, these strategies require further investigation on a larger scale.
Osborn, Yu, Vasilyadis, Craig, & Blackmore (2017) saw great outcomes from their study on
prescriber continuing education combined with mandated policy change. That study used only a
single hospital emergency department. Replicating this study on a larger scale, by using two
cities of comparable size and demographics, could substantiate the use of that specific strategy.
For example, San Antonio and Austin have very similar demographics and a relatively similar
population size. San Antonio could implement a policy city-wide that all prescribers must use a
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screening tool before prescribing opioids to all patients and implement guidelines on prescribing
such as those used in the aforementioned study. Pre-and post-policy prescribing for both cities
could then be compared to analyze this strategy on a larger scale.
Conclusion
This paper operates within the framework of Nola Pender’s Health Promotion,
specifically under the assumption that health professionals can greatly affect their patients. As
such, recommendations to combat the opioid crisis are directed toward changes in prescriber
behavior as opposed to patient behavior. Opioid risk assessment screening tools and mandated
policy changes for opioid prescribing practices show great promise to decrease the epidemic of
opioid abuse sweeping across the U.S.
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Appendix

Figure 1. Flow chart of study selection for prescriber continuing education.
Number of studies found
using keywords

PubMed

CINAHL

N= 208

N= 222

Number of studies meeting
inclusion criteria
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Number of studies after
excluding duplicates
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55

2
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Number of studies
after using exclusion
criteria

Number of studies selected
based on total content

4
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Figure 2. Flow chart of study selection for prescription drug monitoring programs.
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Figure 3. Flow chart of study selection for risk assessment screening tools.
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Data Tables
Table 1
Summary of studies on the efficacy of prescription drug monitoring programs.
Reference
Purpose
Research
Sample
Method
Question
Alexander et
al.
(2016)

Hackman et
al.
(2014)

Norwood &
Wright
(2016)

Prevention
Strategy

Results
Resulted in a modest
decrease in prescribing and
use. Largest decrease in
prescribers and users with
highest baseline prescribing
and use. 1.4% decrease in
opioid prescriptions, 2.5%
decrease in opioid volume,
5.6% in MME per transaction
PDMPs can be used to assess
high exposure to prescription
opioids. Especially
considering most patients in
the study had been prescribed
opioids within the last year,
many with a benzo
simultaneously prescribed.

To quantify the effect
of
Florida's PDMP and
pill mill laws on
overall and highrisk opioid prescribin
g and use.

Will the use of a
PDMP decrease
opioid prescribing
and/ or use?

Cohort of
prescribers, retail
pharmacies and
patients in Florida
(compared to
control state
Georgia)

Measured total opioid
volume, mean morphine
milligram equivalent
(MME) per transaction
and mean days’ supply
per transaction

Prescription
drug
monitoring
program

To better understand
the link between
patients receiving
dual diagnosis
(mental health and
substance abuse)
treatment and prior
opioid prescriptions
using a PDMP.
Examine how the
integration and
consistent use of a
PDMP in
pharmacy practice
impacts pharmacists’
dispensing practices
related to CSPs.

Do patients
receiving
treatment for a
dual diagnosis
have a history of
receiving opioid
prescriptions
within the last
year?
Will the
integration of
PDMPs in
pharmacy practice
improve a
pharmacist’s
ability to make
informed clinical
decisions and
exercise sound
professional
judgment?

Patients in an
Indiana-based
community
mental health
center, receiving
treatment for a
dual diagnosis.
N= 201

Double blind evaluation
compiling information
for a 12-month period.
Researchers gathered
data from the mental
health clinic’s electronic
records while also
gathering data from the
Indiana PDMP.
Cross sectional study
conducted through a
study sent to over 10,000
pharmacists in Indiana
state. The study
measured three outcome
variables: (1)
dispensation change, (2)
refused dispensations, (3)
and annual refusals.

Prescription
drug
monitoring
program

Pharmacists in the
state of Indiana.
The sample
accurately
represents the
pharmacist
workforce with
regards to age,
experience and
gender. N= 1,582

Prescription
drug
monitoring
program

May improve a pharmacist’s
ability to make
informed clinical decisions
and exercise sound
professional judgment.
Dispensation change was 6.4
times more likely. Refused
dispensations were 3.3 more
likely with use of PDMP.
Annual refusals for providers
using PDMP were about 25
compared to 7.
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Reisman,
Shenoy,
Atherly, &
Flowers
(2009)

Examine the link
between state medical
shipments of
prescription opioids
and prescription
opioid
abuse admissions.
Evaluate efficacy of
PDMPs.

Do PDMP
decrease amount
of oxycodone
shipment and/or
prescription
opioid abuse
admissions?

Ringwalt et
al.
(2015)

Use metrics and
PDMP to identify
prescribers with
unusual or
uncustomary
prescribing practices

Do providers who
over-prescribe
controlled
substances
contribute to the
opioid epidemic?

States with active
and stable PDMPs
during the years
1997-2003. These
states included:
CA, HI, IL, IND,
MA, MI, NY,
OK, TX, ID, KY,
NV, RI,
& UT.
Providers
registered in the
North Carolina
Prescription Drug
Monitoring
Program.
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Retrospective ecological
cohort study that
compares state
prescription opioid
shipments for medical
use and abuse admissions
for prescription opioids.

Prescription
drug
monitoring
program

States with PDMPs saw
lower rates of opioid
(oxycodone) shipments and
prescription opioid abuse
admissions. Furthermore,
patients admitted to drug
rehab in PDMP states were
usually not there for
prescription opioids.

Researchers used death
records from the state's
vital records database
and linked them with
providers who wrote
prescriptions to patients
who then died of a
medication or drug
overdose within 30 days

Prescription
drug
monitoring
program

High correlation between
prescribers of controlled
substances, who coprescribed benzodiazepines
and high levels of opioid
analgesics to their patients
and patient overdose/ death.

Table 2
Summary of studies on the efficacy of risk assessment screening tools.
Reference
Purpose
Research
Sample
Question
Aldrige,
Linford, &
Bray
(2017)

Compare substance use
behaviors before
completing a screening
tool and after to assess
for differences. Also to
provide some criticism
for a previously
conducted study about
screening tools.

Will utilizing a
Screening, Brief
Intervention
Referral to
Treatment
(SBIRT) tool
change
substance use
behaviors when
analyzed before
and after
completion?

Patients utilizing
providers who
received the US
Substance Abuse
and Mental
Health Services
Administration
(SAMHSA) grant
to implement
SBIRT in
practice.
N= 17,575
patients with

Method

Prevention
Strategy

Results

Organizations using the
SBIRT provided data for
patients with substance
abuse. Pre-SBIRT and 6months post-SBIRT data
was collected and
compared for 17,575
patients.

Risk
Assessment
Screening
Tool

Significant decreases in
substance abuse were found
in post-SBIRT patient data.
Illicit drug use decreased by
75.8%. Furthermore, the
intensity of the intervention
has a proportionate
relationship with success of
substance abuse prevention.
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Barclay,
Owens, &
Blackhall
(2014)

To assess whether risk
factors for substance
abuse could predict
abnormal urinalysis
results.

Do risk factors
indicated in the
Opioid Risk
Tool predict
subsequent
abnormalities in
drug urine
panels amongst
cancer patients
receiving
palliative care?

Bogdanowicz
et al.
(2016)

To examine the efficacy
of addiction-specific risk
screenings in predicting
high mortality risk
groups.

Do addiction
specific brief
risk screening
tools effectively
identify high
mortality risk
groups?

To analyze opioid abuse
risk factors and
mitigation practices by
using the Stratification
Tool for Opioid
Mitigation Risk
(STORM)

Does STORM
accurately
indicate and
prioritize
patients that
display opioid
abuse risk
factors?

Oliva et al.
(2017)

substance abuse.
Cancer patients at
the University of
Virginia palliative
care clinic,
receiving care in
the month of
September, 2012.
N=114

Inhabitants of
South London
and Maudsley,
that were
identified as
having an opioid
use disorder
(OUD). Patients
were identified
during the time
period between
April, 2008 to
31st March, 2014.
N=4,488
Patients utilizing
the VHA who
received a
prescription for
opioids during
the 2010 fiscal
year. N=
1,135,601
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Electronic medical records
of patients were analyzed
to compute an Opioid Risk
Tool (ORT) score and
scores were recorded. OPT
scores were then
compared to results of
urine drug screens to
examine any correlation
between a predicted high
risk and abnormal drug
screen.
Patient with an OUD were
identified in the case
register database.
Information for each
patient was used to
complete a risk assessment
on them. After completing
this data, death certificates
were searched in the
Office for National
Statistics General Records
Office
to see if any of these
patients had died of an
overdose.
Use electronic medical
records from the VHA to
estimate risk. STORM risk
factors include:
demographics, previous
overdose/suicide
information, prescription
strength and concurrent
sedative medications,
substance abuse and
mental health disorders.
This information was used

Risk
Assessment
Screening
Tool

High risk scores from the
OPT strongly predicted
abnormal urine drug screens.
Only 7% of people who
scored low-risk on the OPT
had abnormal drug test
results. However, 62.5%
percent of people who
received medium-high risk
scores had abnormalities in
their drug screen.

Risk
Assessment
Screening
Tool

“Diagnosis-specific brief
risk screening can identify
OUD patient subgroups at
increased risk of all-cause
and overdose mortality.”

Risk
Assessment
Screening
Tool

STORM analysis results
indicate that informatics can
be successfully used to
identify and mitigate the risk
of opioid abuse and/or
overdose. “For example, the
mean risk
score among the 1,000
patients with the highest risk
scores was
57.9 with 53.7%
(approximately 1 out of
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to calculate patient scores.

Table 3
Summary of studies on the efficacy of prescriber continuing education.
Reference
Purpose
Research
Sample
Question
Holliday et
al.
(2017)

To fill current
knowledge gap:
objectively
analyze the
effect of
education for
pain
management on
opioid
prescribing
rates.

Will providing
education about
pain management
to physicians
affect “real-world
practice behavior”
of prescribing
opioids?

Registrars (the
Australian
equivalent to
medical residents) in
5 regional training
providers (RTP).
One RTP was the
experimental group
that received the
training and the
other 4 RTPs were
the control. N=849.
Of the 849, 42
received the
training.

Kahan et al.
(2013)

To evaluate
whether a twoday intensive
course on
opioid
prescribing
effectively
reduces the
amount of
opioid
prescriptions
written by
providers.

Will a statistically
significant effect
on opioid
prescribing
patterns by
observed after
providers
complete a twoday intensive
training on opioid
prescribing?

Physicians based in
Ontario that
complete the twoday intensive
training course
between the years
2000-2008. 61%
self-referred, 39%
referred by the
College of
Physicians and
Surgeons in Ontario
(CPSO). N =138.

every 2 patients in this
group having an overdose or
suicide related event)”

Method

Prevention
Strategy

Results

A nonequivalent control
group design nested within an
ongoing cohort study was
used. A training workshop
was provided to all registrars
in a single regional training
center. After the training,
opioid prescriptions were
monitored to assess for
changes as compared to the
control group. The control
group was comprised of
registrars at different regional
training centers that did not
receive the educational
training.
Population-based
retrospective cohort study.
Physicians who took the
course were matched with a
control group of physicians
who did not take the course.
The course covered
information on chronic pain,
interviewing techniques,
prescribing, and addiction.
Using broken-line
longitudinal regression, total
amounts of opioids dispensed
were calculated for both the

Prescriber
continuing
education

No significant effect on
opioid prescribing rates after
providers completed
continuing education
compared to control groups.
There was a slight decrease
in initial opioid
prescriptions after the
training but the training
failed to increase overall
opioid cessation.

Prescriber
continuing
education

There was not an immediate
(1 year) nor long term (2
years) reduction in opioid
prescribing rate when
comparing the experimental
group to the control group.
One exception to this was
with the physicians referred
by the CPSO. This subgroup
demonstrated a decline in
opioid prescribing rate to
young patients in both the
immediate and long term
categories.
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Alford,
Hayes,
Zisblatt,
Peloquin,
Hardesty, &
White
(2015)

Osborn, Yu,
Williams,
Vasilyadis,
Craig, &
Blackmore
(2017)

To assess the
efficacy of the
Safe and
Competent
Opioid
Prescribing
Education
(SCOPE of
Pain) program
on prescriber
knowledge,
attitudes,
confidence, and
self-reported
clinical practice
in safe opioid
prescribing.
To determine
how the
implementation
of a prescription
policy for
opioids effects
overall opioid
prescribing
patterns in an
emergency
department
(ED) .

Will undergoing
SCOPE of Pain
training alter
provider’s
knowledge,
attitude,
confidence and
self-reported safe
opioid prescribing
patterns?

Participants who
completed the
SCOPE of Pain
training between the
years 2013-2014.
This study focused
on providers who
manage chronic pain
such as physicians,
physician assistants,
and nurse
practitioners.
N=2,850 (complete
first two surveys)
N=476 (completed
all 3 surveys)

Will a
collaborative staff
educational
initiative to train
ED providers on
new opioid
prescribing
policies have a
statistically
significant effect
on overall opioid
prescribing
patterns in the
hospital ED?

Patients at an urban,
non-university,
teaching hospital in
the Pacific
Northwest.
Participants were
age 18 and older
between 2007 and
2014.
N= 116,676
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experimental and control
group.
Participants included in the
survey completed the Scope
of Pain training. They
completed pre, immediate
post program, and 2 month
post program self-reported
quantitative assessment
surveys. Surveys included
questions about knowledge,
confidence, attitude, and
clinical performance
(prescribing). Paired t-tests
were used to establish change
in clinical practice two
months after participation.

Pre-intervention and postintervention time series study
in which the ED opioid
prescribing rate was analyzed
before the education on
policy change and then after
using. Policy changes were
based on the Washington ED
opioid abuse Work Group
guidelines. Information about
prescribing patterns was
retrieved retrospectively from
electronic medical records.
The years 2007-2010
comprised the preintervention time frame and
2012-2014 was the postintervention time frame.

Prescriber
continuing
education

The SCOPE “Improved
clinician-level safe opioid
prescribing outcomes,
however, its impact on
mitigating opioid misuse
risk and harm while
maintaining access to
opioids for those that are or
would benefit remains an
unanswered question.”

Prescriber
continuing
education

The intervention resulted in
a 39% decrease in patients
discharged with an opioid
prescription from the ED.
Additionally, these changes
in prescribing patterns were
sustained when analyzed at a
2.5 year follow-up.

